Hi everyone, earlier this year we surveyed some GCA patients (members of the charity and on our forum here) who had previously been prescribed tocilizumab but had had to stop taking it at the end of the allowed period. The results clearly illustrate the unmet need for better treatment options for English patients who stop tocilizumab and then have a GCA relapse. Importantly, it brings to life the results found in TOC STOP where up to half of people with GCA had a relapse after they stopped tocilizumab.
We wrote the following article about the survey for Rheumatology Advances in Practice which is an internationally recognised rheumatology journal. It is now published and will come up on searches in Pubmed, which is the way anyone looking for research on GCA would be able to access the article anywhere in the world.
We have also paid for it to be open access so anyone can see it, to maximise its reach (this was the only way to publish it in this journal where everything is open access, but other journals make you pay for your paper to be open access too).
This article will be used as evidence in a presentation to NHS England asking for a change of their policy so people can have repeat treatment with tocilizumab if they relapse.
You can read the article here: academic.oup.com/rheumap/ar...
Special thanks to the patients who participated and to our trustee, Dr Vanessa Quick and patron, Dr Sarah Mackie for their involvement.
#GCA #GiantCellArteritis #TOCSTOP